Skip to main content
. 2019 Jul 11;18(3):3202–3210. doi: 10.3892/ol.2019.10603

Table I.

Pathological results of all BI-RADS 4 category breast lesions, [n (%)].

Lesions n (%)
Malignant 30 (25.9)
  Invasive ductal carcinoma 17 (56.7)
  Ductal carcinoma in situ 6 (20.0)
  Tubular carcinoma 2 (6.7)
  Invasive lobular carcinoma 2 (6.7)
  Mucinous carcinoma 3 (10.0)
Benign 86 (74.1)
  Papilloma 7 (8.1)
  Fibroadenoma 23 (26.7)
  Fibrocystic change 24 (27.9)
  Ductal hyperplasia 18 (20.9)
  Sclerosing adenosis 3 (3.5)
  Columnar cell lesions 11 (12.8)